Institutional members access full text with Ovid®

Share this article on:

The Sydney Blood Bank Cohort: implications for viral fitness as a cause of elite control

Zaunders, Johna; Dyer, Wayne Bb,c; Churchill, Melissad,e

Current Opinion in HIV and AIDS: May 2011 - Volume 6 - Issue 3 - p 151–156
doi: 10.1097/COH.0b013e3283454d5b
Elite controllers: Edited by Steven G. Deeks, Alexandre Harari and Joel Blankson

Purpose of review The Sydney Blood Bank Cohort comprised eight individuals who were infected with an attenuated, nef/LTR-deleted strain of HIV-1 from a single donor. All six recipients with sufficient follow-up, as well as the donor, were long-term nonprogressors. Only three recipients have maintained undetectable plasma viral loads, allowing investigation of factors that determined elite control of attenuated HIV-1 infection.

Recent findings Follow-up of recipients showed that infection with this attenuated HIV-1 strain resulted in either low or absent viral replication in vivo for up to 29 years. The three patients without detectable viraemia have been studied for virological, genetic and immunological correlates of elite control. CD4 proliferation in vitro in response to p24 provided the clearest distinction of elite controllers from the slow progressors. Host factors are believed to differentiate the three elite controllers; only one, C135, has identifiable genetic polymorphisms that probably contributed to nonprogression: Δ32 CCR5 heterozygosity, HLA-B57 and HLA-DR13 alleles, in addition to infection with nef-defective HIV-1.

Summary Even nef-defective HIV-1 can lead to sufficient replication in vivo to enable viral evolution and eventual progression to immunodeficiency. Host factors modified the outcome of infection with attenuated HIV-1, as exemplified by the unique patient C135.

aCentre for Applied Medical Research, St. Vincent's Hospital, University of New South Wales, Australia

bResearch and Business Development, Australian Red Cross Blood Service, Australia

cTransfusion Medicine and Immunogenetics Research Unit, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia

dCentre for Virology, Macfarlane Burnet Institute for Medical Research and Public Health, Australia

eDepartment of Medicine, Monash University, Melbourne, Victoria, Australia

Correspondence to John Zaunders, Centre for Applied Medical Research, Level 9 Lowy Packer Building, St. Vincent's Hospital, Victoria Street, Darlinghurst, NSW 2010, Australia Tel: +61 2 8382 4945; fax: +61 2 8382 4967; e-mail:

© 2011 Lippincott Williams & Wilkins, Inc.